XLY — Auxly Cannabis Income Statement
0.000.00%
Last trade - 00:00
- CA$68.82m
- CA$212.12m
- CA$101.08m
- 52
- 66
- 85
- 76
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 8.35 | 46.7 | 83.8 | 94.5 | 101 |
Cost of Revenue | |||||
Gross Profit | -2.95 | 9.28 | 16.9 | -11.3 | 5.07 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 116 | 121 | 130 | 234 | 148 |
Operating Profit | -108 | -74.6 | -46.4 | -140 | -47 |
Total Net Non Operating Interest Income / Expense | |||||
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -120 | -86.6 | -50.2 | -137 | -47.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | -109 | -85.9 | -45.9 | -130 | -44.5 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -103 | -85.4 | -33.7 | -130 | -44.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -103 | -85.4 | -33.7 | -130 | -44.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.13 | -0.117 | -0.069 | -0.118 | -0.059 |